385 related articles for article (PubMed ID: 10334627)
21. Inhalation of benzene leads to an increase in the mutant frequencies of a lacI transgene in lung and spleen tissues of mice.
Mullin AH; Rando R; Esmundo F; Mullin DA
Mutat Res; 1995 Mar; 327(1-2):121-9. PubMed ID: 7870081
[TBL] [Abstract][Full Text] [Related]
22. Tamoxifen induces G:C-->T:A mutations in the cII gene in the liver of lambda/lacI transgenic rats but not at 5'-CpG-3' dinucleotide sequences as found in the lacI transgene.
Davies R; Gant TW; Smith LL; Styles JA
Carcinogenesis; 1999 Jul; 20(7):1351-6. PubMed ID: 10383911
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of the in vivo genotoxic potential of three carcinogenic aromatic amines using the Big Blue transgenic mouse mutation assay.
Suter W; Ahiabor R; Blanco B; Locher F; Mantovani F; Robinson M; Sreenan G; Staedtler F; Swingler T; Vignutelli A; Perentes E
Environ Mol Mutagen; 1996; 28(4):354-62. PubMed ID: 8991064
[TBL] [Abstract][Full Text] [Related]
24. Mutational spectrum of dimethylnitrosamine in the liver of 3- and 6-week-old lacI transgenic mice.
de Boer JG; Mirsalis JC; Glickman BW
Environ Mol Mutagen; 1999; 34(2-3):80-3. PubMed ID: 10529729
[TBL] [Abstract][Full Text] [Related]
25. Detection of cyclophosphamide-induced mutations at the Hprt but not the lacI locus in splenic lymphocytes of exposed mice.
Walker VE; Andrews JL; Upton PB; Skopek TR; deBoer JG; Walker DM; Shi X; Sussman HE; Gorelick NJ
Environ Mol Mutagen; 1999; 34(2-3):167-81. PubMed ID: 10529741
[TBL] [Abstract][Full Text] [Related]
26. A new transgenic mouse mutagenesis test system using Spi- and 6-thioguanine selections.
Nohmi T; Katoh M; Suzuki H; Matsui M; Yamada M; Watanabe M; Suzuki M; Horiya N; Ueda O; Shibuya T; Ikeda H; Sofuni T
Environ Mol Mutagen; 1996; 28(4):465-70. PubMed ID: 8991079
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of mutant frequencies of chemically induced tumors and normal tissues in lambda/cII transgenic mice.
Mirsalis JC; Shimon JA; Johnson A; Fairchild D; Kanazawa N; Nguyen T; de Boer J; Glickman B; Winegar RA
Environ Mol Mutagen; 2005; 45(1):17-35. PubMed ID: 15605353
[TBL] [Abstract][Full Text] [Related]
28. Reporter gene transgenic mice as a tool for analyzing the molecular mechanisms underlying experimental carcinogenesis.
Nishikawa A; Suzuki T; Masumura K; Furukawa F; Miyauchi M; Nakamura H; Son HY; Nohmi T; Hayashi M; Hirose M
J Exp Clin Cancer Res; 2001 Mar; 20(1):111-5. PubMed ID: 11370817
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of mutagenic mode of action in Big Blue mice fed methylphenidate for 24 weeks.
Manjanatha MG; Shelton SD; Dobrovolsky VN; Shaddock JG; McGarrity LG; Twaddle NW; Moore MM; Mattison DR; Slikker W; Morris SM
Mutat Res; 2009; 680(1-2):43-8. PubMed ID: 19778631
[TBL] [Abstract][Full Text] [Related]
30. Increased mutant frequency and altered mutation spectrum of the lacI transgene in Wilson disease rats with hepatitis.
Sone H; Li YJ; Ishizuka M; Aoki Y; Nagao M
Cancer Res; 2000 Sep; 60(18):5080-6. PubMed ID: 11016632
[TBL] [Abstract][Full Text] [Related]
31. Organ variation in the mutagenicity of ethylnitrosourea in Muta mouse: results of the collaborative study on the transgenic mutation assay by JEMS/MMS. The Collaborative Study Group for the Transgenic Mouse Mutation Assay Mammalian Mutagenesis Study Group of the Environmental Mutagen Society of Japan.
Environ Mol Mutagen; 1996; 28(4):363-75. PubMed ID: 8991065
[TBL] [Abstract][Full Text] [Related]
32. Mutational spectra of tamoxifen-induced mutations in the livers of lacI transgenic rats.
Davies R; Oreffo VI; Bayliss S; Dinh PA; Lilley KS; White IN; Smith LL; Styles JA
Environ Mol Mutagen; 1996; 28(4):430-3. PubMed ID: 8991074
[TBL] [Abstract][Full Text] [Related]
33. Elevated mutant frequencies in gene lacI in splenic lipopolysaccharide blasts after exposure to activated phagocytes in vitro.
Felix K; Lin S; Janz S
Eur J Immunol; 1997 Sep; 27(9):2160-4. PubMed ID: 9341754
[TBL] [Abstract][Full Text] [Related]
34. Mutant frequency of lacI in transgenic mice following benzo[a]pyrene treatment and partial hepatectomy.
Shane BS; Lockhart AM; Winston GW; Tindall KR
Mutat Res; 1997 Jun; 377(1):1-11. PubMed ID: 9219573
[TBL] [Abstract][Full Text] [Related]
35. In vivo mutagenicity of ethylene oxide at the hprt locus in T-lymphocytes of B6C3F1 lacI transgenic mice following inhalation exposure.
Walker VE; Sisk SC; Upton PB; Wong BA; Recio L
Mutat Res; 1997 Aug; 392(3):211-22. PubMed ID: 9294020
[TBL] [Abstract][Full Text] [Related]
36. Relative sensitivity of the endogenous hprt gene and lacI transgene in ENU-treated Big Blue B6C3F1 mice.
Skopek TR; Kort KL; Marino DR
Environ Mol Mutagen; 1995; 26(1):9-15. PubMed ID: 7641713
[TBL] [Abstract][Full Text] [Related]
37. A more efficient Big Blue protocol improves transgene rescue and accuracy in a adduct and mutation measurement.
Bielas JH
Mutat Res; 2002 Jul; 518(2):107-12. PubMed ID: 12113761
[TBL] [Abstract][Full Text] [Related]
38. Species-specific differences in hepatic mutant frequency and mutational spectrum among lambda/lacI transgenic rats and mice following exposure to aflatoxin B1.
Dycaico MJ; Stuart GR; Tobal GM; de Boer JG; Glickman BW; Provost GS
Carcinogenesis; 1996 Nov; 17(11):2347-56. PubMed ID: 8968048
[TBL] [Abstract][Full Text] [Related]
39. p53 wild-type and p53 nullizygous Big Blue transgenic mice have similar frequencies and patterns of observed mutation in liver, spleen and brain.
Nishino H; Knöll A; Buettner VL; Frisk CS; Maruta Y; Haavik J; Sommer SS
Oncogene; 1995 Jul; 11(2):263-70. PubMed ID: 7624143
[TBL] [Abstract][Full Text] [Related]
40. Spontaneous mutants recovered from liver and germ cell tissue of low copy number lacI transgenic rats.
de Boer JG; Erfle H; Holcroft J; Walsh D; Dycaico M; Provost S; Short J; Glickman BW
Mutat Res; 1996 Jun; 352(1-2):73-8. PubMed ID: 8676919
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
